View Post

Universal Cancer Vaccine Candidate Presents Positive Long-term Benefits

In COVID-19, Latest News by Precision Vaccinations

A clinical-stage leader in immune-stimulatory vaccines for cancer announced the publication of its favorable long-term Overall Survival (OS) data from a Phase I trial evaluating a universal cancer vaccine candidate, UV1, in combination with checkpoint inhibitor ipilimumab, in patients with metastatic malignant melanoma.
UV1 is a peptide-based vaccine inducing a specific T cell response against the universal cancer antigen telomerase. 

View Post

Tuberculosis Vaccine Recommendations Launch Update Process

In COVID-19, Latest News by Precision Vaccinations

The World Health Organization (WHO) announced it is convening a Guideline Development Group to advise on updates to its recommendations on managing tuberculosis (TB) in children and adolescents.
Despite significant progress and greater understanding of the challenges faced in addressing TB in children and adolescents, critical gaps remain in TB case detection and provision of TB preventive treatments, stated the WHO on May 7, 2021.
The first edition of Guidance for national tuberculosis programs on the management of tuberculosis in children was published in 2006.